BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38826482)

  • 1. Deletion of adipocyte Sine Oculis Homeobox Homolog 1 prevents lipolysis and attenuates skin fibrosis.
    Wareing N; Mills TW; Collum S; Wu M; Revercomb L; Girard R; Lyons M; Skaug B; Bi W; Ali MA; Koochak H; Flores AR; Yang Y; Zheng WJ; Swindell W; Assassi S; Karmouty-Quintana H
    bioRxiv; 2024 May; ():. PubMed ID: 38826482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sine oculis homeobox homolog 1 plays a critical role in pulmonary fibrosis.
    Wilson C; Mertens TC; Shivshankar P; Bi W; Collum SD; Wareing N; Ko J; Weng T; Naikawadi RP; Wolters PJ; Maire P; Jyothula SS; Thandavarayan RA; Ren D; Elrod ND; Wagner EJ; Huang HJ; Dickey BF; Ford HL; Karmouty-Quintana H
    JCI Insight; 2022 May; 7(10):. PubMed ID: 35420997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.
    Marangoni RG; Korman BD; Wei J; Wood TA; Graham LV; Whitfield ML; Scherer PE; Tourtellotte WG; Varga J
    Arthritis Rheumatol; 2015 Apr; 67(4):1062-73. PubMed ID: 25504959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.
    Akamata K; Asano Y; Aozasa N; Noda S; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sato S
    Arthritis Res Ther; 2014 Apr; 16(2):R86. PubMed ID: 24708674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
    Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
    Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
    Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
    Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-448-5p inhibits TGF-β1-induced epithelial-mesenchymal transition and pulmonary fibrosis by targeting Six1 in asthma.
    Yang ZC; Qu ZH; Yi MJ; Shan YC; Ran N; Xu L; Liu XJ
    J Cell Physiol; 2019 Jun; 234(6):8804-8814. PubMed ID: 30362537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of TLR7 and TLR9 in the Pathogenesis of Systemic Sclerosis.
    Wang C; Oishi K; Kobayashi T; Fujii K; Horii M; Fushida N; Kitano T; Maeda S; Ikawa Y; Komuro A; Hamaguchi Y; Matsushita T
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis.
    Zhang L; Zheng D; Yan Y; Yu Y; Chen R; Li Z; Greer PA; Peng T; Wang Q
    Arthritis Res Ther; 2022 Jun; 24(1):148. PubMed ID: 35729674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis.
    Jiang Y; Hu F; Li M; Li Q
    Clin Exp Pharmacol Physiol; 2024 Feb; 51(2):e13834. PubMed ID: 38037494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sine oculis homeobox homolog 1 promotes α5β1-mediated invasive migration and metastasis of cervical cancer cells.
    Liu D; Zhang XX; Wan DY; Xi BX; Ma D; Wang H; Gao QL
    Biochem Biophys Res Commun; 2014 Apr; 446(2):549-54. PubMed ID: 24613848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.
    Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    Exp Dermatol; 2016 Apr; 25(4):287-92. PubMed ID: 26661692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleroderma-like Impairment in the Network of Telocytes/CD34
    Rosa I; Romano E; Fioretto BS; Guasti D; Ibba-Manneschi L; Matucci-Cerinic M; Manetti M
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?
    Wei J; Melichian D; Komura K; Hinchcliff M; Lam AP; Lafyatis R; Gottardi CJ; MacDougald OA; Varga J
    Arthritis Rheum; 2011 Jun; 63(6):1707-17. PubMed ID: 21370225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma.
    Castelino FV; Seiders J; Bain G; Brooks SF; King CD; Swaney JS; Lorrain DS; Chun J; Luster AD; Tager AM
    Arthritis Rheum; 2011 May; 63(5):1405-15. PubMed ID: 21305523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis.
    Desallais L; Avouac J; Fréchet M; Elhai M; Ratsimandresy R; Montes M; Mouhsine H; Do H; Zagury JF; Allanore Y
    Arthritis Res Ther; 2014 Jul; 16(4):R157. PubMed ID: 25059342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis.
    Bhattacharyya S; Wang W; Tamaki Z; Shi B; Yeldandi A; Tsukimi Y; Yamasaki M; Varga J
    Front Immunol; 2018; 9():2434. PubMed ID: 30405628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detrimental role of SIX1 in hepatic lipogenesis and fibrosis of non-alcoholic fatty liver disease.
    Gao X; Chu Y; Wang W; Li W; Zhang W; Cao J; Fu X; Liu H; Chen D; Fan D; Nie Y
    Liver Int; 2023 Jul; 43(7):1473-1485. PubMed ID: 37088973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleomycin inhibits adipogenesis and accelerates fibrosis in the subcutaneous adipose layer through TGF-β1.
    Ohgo S; Hasegawa S; Hasebe Y; Mizutani H; Nakata S; Akamatsu H
    Exp Dermatol; 2013 Nov; 22(11):769-71. PubMed ID: 24118261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of leucine-rich α-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model.
    Nakajima H; Nakajima K; Serada S; Fujimoto M; Naka T; Sano S
    Mod Rheumatol; 2021 Nov; 31(6):1120-1128. PubMed ID: 33535851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.